Publications

Switching from Double-Blind Entacapone or Placebo to Open-Label Opicapone: Change in Off-/On-Time from Patients Who Ended the 1-Year Bipark-I Extension on Opicapone 50 Mg

AuthID
P-00R-WDE

Author(s)

Ferreira, J

Lees, A

Rascol, O

Poewe, W

Ikedo, F

Magalhaes, D

Rocha, F

Soares da Silva, P

Document Type

Abstract

Year published

2019

Published

in JOURNAL OF THE NEUROLOGICAL SCIENCES, ISSN: 0022-510X

Volume: 405

Conference

World Congress of Neurology (Wcn), Date: OCT 27-31, 2019, Location: Emirates Neurol Soc, Dubai, U ARAB EMIRATES, Sponsors: World Federat Neurol, Host: Emirates Neurol Soc

Indexing

Wos^®

Google Scholar^®

Metadata
Sources

Publication Identifiers

DOI: 10.1016/j.jns.2019.10.1208

Wos: WOS:000516770700421

Source Identifiers

ISSN: 0022-510X

Export Publication Metadata

Marked List

Add to Marked List

Info

At this moment we don't have any links to full text documens.

Switching from Double-Blind Entacapone or Placebo to Open-Label Opicapone: Change in Off-/On-Time from Patients Who Ended the 1-Year Bipark-I Extension on Opicapone 50 Mg

Useful Links

Get Help

Federated Authentication (Click on the image)

Switching from Double-Blind Entacapone or Placebo to Open-Label Opicapone: Change in Off-/On-Time from Patients Who Ended the 1-Year Bipark-I Extension on Opicapone 50 Mg

Useful Links

Get Help